Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
about
Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targetsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementAntigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesImmune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceThe mechanism of anti-CD20-mediated B cell depletion revealed by intravital imagingRestoring the balance: immunotherapeutic combinations for autoimmune diseaseTesting agents for prevention or reversal of type 1 diabetes in rodents.Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessmentThe microRNA-212/132 cluster regulates B cell development by targeting Sox4.T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitisImmune interventions to preserve β cell function in type 1 diabetesClinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor MiceTargeted immune interventions for type 1 diabetes: not as easy as it looks!Antigen-specific immunotherapies in rheumatic diseases.
P2860
Q26751244-B7815E65-6EFD-4C97-B5AE-01014D198612Q26769878-2D8DF846-E1A4-4488-BD0F-2C82F0716E3EQ26770386-8F7C8FEB-A339-42B8-9726-9F9F52B1BDBEQ26850621-B8260D57-E710-49FA-861F-683E6902DE91Q30559277-F6FCF262-03E9-4263-B1BB-570ACC0C9500Q33555986-C96A9C4D-CD2A-479A-BA86-AD69AC4D73BAQ34983677-40AE83A4-0B91-40AD-B562-09376BD9F5CAQ35041294-BB62BC5B-5E5D-407A-925B-F0304EBA7A8BQ36080716-4F896723-490C-4337-A170-BAF629F5763FQ36093770-70A54468-9195-4991-BF3D-FB6C91F0EC37Q36520618-7BC63981-A025-4D26-B184-5D6A11AA6F04Q36709163-2570ED76-0788-41AB-A5C2-7FA029BAEA3AQ37222143-D5BB74D2-E368-4B1F-92CE-74B781DAD70BQ37434315-A6CBC99E-3E01-44D9-B4A6-CEE7E62694D8Q38225173-86FE9915-0785-4C3F-8E63-9D9D8756752FQ39431371-12658CDB-7612-4B8A-87D1-A143B8F10470
P2860
Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@ast
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@en
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@nl
type
label
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@ast
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@en
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@nl
prefLabel
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@ast
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@en
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@nl
P2093
P2860
P50
P1433
P1476
Transient B-cell depletion wit ...... ects and efficacy in NOD mice.
@en
P2093
Andrew C Chan
Darius Schneider
Ghanashyam Sarikonda
Hideki Garren
Kevan Herold
Laura Straub
Lawrence Steinman
Marilyne Coulombe
Mario Ehlers
Mark Atkinson
P2860
P304
P356
10.1371/JOURNAL.PONE.0054712
P407
P577
2013-02-06T00:00:00Z